Cardiovascular disease: identifying and supporting people most at risk of dying early

took place with smokers in the UK and is relevant to this review. Evidence statement 7SM Two American studies suggest the need to test existing cessation interventions to determine their suitability for the specific group, to receive feedback from that group and to make amendments to any aspects that are unsuitable. In order for the client group to benefit, the intervention must fit their level of need and understanding, and be suitably accessible. (One USA-based RCT [++], and 1 USA-based cohort study [-].) Evidence statement 8SM There is evidence from a number of studies that training pharmacists to deliver smoking cessation interventions is important and that pharmacies may be a valuable means of reaching disadvantaged individuals and increasing their smoking cessation rates (1 UK systematic review comprising 2 RCTs and 3 non-randomised experimental studies [++], 1 UK observational study with interviews [++] and 1 international pilot study [+]). Two studies took place within the UK and are directly applicable to the review. One took place in the USA and so may have limited applicability to this review. Evidence statement 9SM There is evidence from 3 reviews that training dental professionals to deliver smoking cessation interventions is important, and that this
